Search Result "infigratinib"
Pharmacophore Based Design of Probable FGFR-1 Inhibitors from the 3DCrystal Structure of Infigratinib - A Drug Used in the Treatment ofCholangiocarcinomas
Journal: Letters in Drug Design & Discovery
Volume: 19 Issue: 4 Year: 2022 Page: 314-322
Author(s): Koushik Sarker,Avijit Ghosh,Abhijit Saha,Suvasish Mishra,Subrata Sen
An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs(2018-2021)
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 24 Issue: 8 Year: 2024 Page: 590-626
Author(s):
Epigallocatechin-3-gallate Induced HepG2 Cells Apoptosis through ROSmediatedAKT /JNK and p53 Signaling Pathway
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 6 Year: 2023 Page: 447-460
Author(s):
Cholangiocarcinoma Therapeutics: An Update
Journal: Current Cancer Drug Targets
Volume: 21 Issue: 6 Year: 2021 Page: 457-475
Author(s): Mai Ly Thi Nguyen,Nguyen Linh Toan,Maria Bozko,Khac Cuong Bui,Przemyslaw Bozko
The Structureâproperty Relationships of Clinically Approved ProteinKinase Inhibitors
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 22 Year: 2023 Page: 2518-2541
Author(s):
US-FDA Approved Drugs in 2020 and 2021: A Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2023 Page: 1273-1297
Author(s):
Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis
Journal: Current Cancer Drug Targets
Volume: 18 Issue: 10 Year: 2018 Page: 979-987
Author(s): Ana Sahores,MarÃa May,Gonzalo R. Sequeira,Cynthia Fuentes,Britta Jacobsen,Claudia Lanari,Caroline A. Lamb
To Investigate Growth Factor Receptor Targets and Generate CancerTargeting Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 23 Issue: 30 Year: 2023 Page: 2877-2972
Author(s):
Therapeutic Targeting of the Tumor Vasculature: Past, Present and Future
Ebook: Anti-Angiogenesis Drug Discovery and Development
Volume: 5 Year: 2020
Author(s): Peace Mabeta,Mike Sathekge,Vanessa Steenkamp
Doi: 10.2174/9789811432873120050003
Growth Factors and Cancer
Ebook: Molecular Targets and Cancer Therapeutics (Part 1)
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815080384123010008